Research & Development



  雲瑯明白真正的原因是什麼,這時候如果說出來,那一定是傻子。   司馬遷奇怪的瞅瞅雲瑯,也不再做聲,倒是甦稚連聲催促司馬遷把這個美麗的故事講完。色情五月亚洲中文字幕   如果慈眉善目的去對待敵人……他們一般會覺得你好欺負,當你跟他講理的時候,他一般會對你動刀子。在线观看视频亚洲电影   謝寧對甦稚的興趣從無一下子提高到了極致。   霍去病雖然已經跟匈奴人打了十幾仗,跟白登山比起來還算不上什麼大戰。欧美图片亚洲区图片   雲瑯的身體搖晃了兩下,扶著山洞洞壁這才站穩,顫聲道︰“拖出去!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo